Dyadic International Inc (DYAI)
1.43
-0.07
(-4.67%)
USD |
NASDAQ |
May 03, 16:00
1.43
0.00 (0.00%)
After-Hours: 20:00
Dyadic International Free Cash Flow: -6.727M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.727M |
| September 30, 2023 | -7.485M |
| June 30, 2023 | -7.300M |
| March 31, 2023 | -7.420M |
| December 31, 2022 | -8.084M |
| September 30, 2022 | -9.037M |
| June 30, 2022 | -11.60M |
| March 31, 2022 | -12.22M |
| December 31, 2021 | -11.28M |
| September 30, 2021 | -9.929M |
| June 30, 2021 | -6.978M |
| March 31, 2021 | -6.485M |
| December 31, 2020 | -6.574M |
| September 30, 2020 | -6.688M |
| June 30, 2020 | -6.846M |
| March 31, 2020 | -6.370M |
| December 31, 2019 | -5.783M |
| September 30, 2019 | -5.611M |
| June 30, 2019 | -4.871M |
| March 31, 2019 | -5.156M |
| December 31, 2018 | -4.407M |
| September 30, 2018 | -4.339M |
| June 30, 2018 | -5.232M |
| March 31, 2018 | -1.602M |
| December 31, 2017 | -1.691M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.027M |
| June 30, 2017 | -4.649M |
| March 31, 2017 | -4.637M |
| December 31, 2016 | -6.032M |
| September 30, 2016 | -7.253M |
| June 30, 2016 | -1.559M |
| March 31, 2016 | -2.042M |
| December 31, 2015 | -0.8027M |
| September 30, 2015 | 0.0918M |
| June 30, 2015 | -0.6989M |
| March 31, 2015 | -0.6976M |
| December 31, 2014 | |
| September 30, 2014 | |
| March 31, 2014 | 2.706M |
| December 31, 2013 | 4.690M |
| September 30, 2013 | 4.906M |
| June 30, 2013 | 2.550M |
| March 31, 2013 | -0.8019M |
| September 30, 2012 | 7.975M |
| June 30, 2012 | 6.418M |
| March 31, 2012 | 2.839M |
| December 31, 2006 | 0.271M |
| September 30, 2006 | -10.19M |
| June 30, 2006 | -9.881M |
| March 31, 2006 | -8.298M |
Free Cash Flow Range, Past 5 Years
-12.22M
Minimum
Mar 2022
-4.871M
Maximum
Jun 2019
-7.752M
Average
-6.978M
Median
Jun 2021
Free Cash Flow Benchmarks
| AIM ImmunoTech Inc | -21.85M |
| Perspective Therapeutics Inc | -37.98M |
| Protalix BioTherapeutics Inc | -2.467M |
| Electromed Inc | 3.653M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.9234M |
| Cash from Investing (Quarterly) | 0.0342M |
| Free Cash Flow Per Share (Quarterly) | -0.032 |
| Free Cash Flow to Equity (Quarterly) | -0.9234M |
| Free Cash Flow Yield | -16.33% |